UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549
                               _______________

                                  FORM 8-K

                               CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

             Date of Report (Date of earliest event reported)
                       March 24, 2006 (March 22, 2006)
                               _______________

                        DIALYSIS CORPORATION OF AMERICA
             (Exact name of registrant as specified in its charter)

           Florida                     0-8527               59-1757642
(State or other jurisdiction         (Commission           (IRS Employer
       of incorporation)             File Number)        Identification No.)

1302 Concourse Drive, Suite 204, Linthicum, MD                 21090
   (Address of principal executive offices)                  (Zip Code)

    Registrant's telephone number, including area code: (410) 694-0500

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))



Item 8.01 Other Events

     President and Chief Executive Officer, Stephen W. Everett, adopted a
personal stock trading plan in December 2005, pursuant to, and intended to
comply with, Rule 10b5-1 under the Securities Exchange Act of 1934. In
accordance with the plan, Mr. Everett sold 18,376 shares of the company's
common stock on March 22, 2006.

     Under the stock trading plan, Mr. Everett plans to sell up to 150,000
additional shares of DCAI common stock through September of 2007, subject to
specific minimum price levels and quarterly limitations. The plan was
established as part of Mr. Everett's long-term strategy for asset
diversification and financial and tax planning activities. Rule 10b5-1 allows
corporate officers and directors to adopt written, pre-arranged stock trading
plans when they are not in possession of material, non-public information.
Transactions under this plan will be disclosed publicly through Form 144 and
Form 4 filings as required by the SEC.

                                 SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                       DIALYSIS CORPORATION OF AMERICA

                                          /s/ Stephen W. Everett
                                        By--------------------------------
                                          STEPHEN W. EVERETT
                                          President and Chief Executive
                                             Officer

Dated:  March 24, 2006